| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 09/07/2011 | CN102172354A Use of pentacyclic triterpene organic acid ester derivatives as glycogen phosphorylase inhibitors |
| 09/07/2011 | CN102172353A Application of p-carboxy phenyl ferriporphyrin to prevention and treatment of atherosclerosis |
| 09/07/2011 | CN102172352A Lipoic acid composition for injection and preparation method thereof |
| 09/07/2011 | CN102172347A Oral pharmaceutical formulations comprising fenofibric acid and/or its salts |
| 09/07/2011 | CN101940605B Chinese loropetalum leaf total flavonol extract and medical application thereof |
| 09/07/2011 | CN101884737B Chinese medicinal composition for treating hemiparalysis |
| 09/07/2011 | CN101843763B Traditional Chinese medicine capable of treating complicated symptom of diabetes and stagnant heat and application thereof |
| 09/07/2011 | CN101843607B Composition containing ibutilide fumarate and preparation method and application thereof |
| 09/07/2011 | CN101836997B Glycerol/fructose composite and preparation method thereof |
| 09/07/2011 | CN101829148B Traditional Chinese medicine extractive, oral preparation containing extractive and method for preparing oral preparation |
| 09/07/2011 | CN101816769B Medicament for treating cardiac, cerebral and vascular diseases |
| 09/07/2011 | CN101791318B Novel application of bacterial lipopolysaccharides |
| 09/07/2011 | CN101683338B Application of hirsutine in preparing medicament for treating myocardial damage |
| 09/07/2011 | CN101643509B VEGFR-2 resistant monoclonal antibody with human and mouse cross reaction as well as preparation method and application thereof |
| 09/07/2011 | CN101618184B Traditional Chinese medicine paste for treating chemotherapeutic phlebitis of 2 level and 3 level and preparation |
| 09/07/2011 | CN101597337B Conjugate of hydroxyalkyl starch and an active agent |
| 09/07/2011 | CN101590042B Stable oral medicinal composition |
| 09/07/2011 | CN101559176B Chinese materia medica preparation for lowering blood pressure |
| 09/07/2011 | CN101530590B Pearl capsule with twenty-five components, preparation method and quality detection method thereof |
| 09/07/2011 | CN101485867B Chinese medicinal composition for treating varix and preparation method thereof |
| 09/07/2011 | CN101485858B Application of Chinese herbal medicine hirudo in cerebrovascular disease |
| 09/07/2011 | CN101411810B Medicament for treating multiple sclerosis symptoms |
| 09/07/2011 | CN101269062B Application of loganin in preparing medicament for treating cardiovascular and cerebrovascular diseases |
| 09/07/2011 | CN101235004B Omega-amidosulphonic acid substituted hypocrellin derivatives, preparation method and application thereof |
| 09/07/2011 | CN101214339B Hypertension-treating medicine and preparation thereof |
| 09/07/2011 | CN101203493B Substituted heterocycles, their use as medicament, and pharmaceutical preparations comprising them |
| 09/07/2011 | CN101156936B An administer orally mixed nucleus glycosides as well as its preparing technics |
| 09/07/2011 | CN101134018B Fenofibrate pellet and method for preparing the same |
| 09/07/2011 | CN101035433B Fermented milk or vegetable proteins comprising receptor ligand and uses thereof |
| 09/06/2011 | US8013133 Genetic modification of targeted regions of the cardiac conduction system |
| 09/06/2011 | US8012997 Isoindole-imide compounds, compositions, and uses thereof |
| 09/06/2011 | US8012996 Methods and composition for inhibition of angiogenesis |
| 09/06/2011 | US8012995 Pharmaceutically active sulfonamide derivatives |
| 09/06/2011 | US8012965 e.g. 1-(2-chloro-7-methylthieno[3,2-d]pyrimidin-4-yl)-N3-(5,7-ethano-5,7,8-trihydro-6-methyl-1,6-naphthyridin-3-yl)-1H-1,2,4-triazole-3,5-diamine; angiogenesis inhibitor, antiproliferative agent |
| 09/06/2011 | US8012503 Administering propranolol or a derivative across a mucosal membrane in combination with a buffering agent (phosphate buffer) to provide a pH of 7.6 at the membrane; sublingual; cardiovascular disorders |
| 09/06/2011 | US8012496 Gastric retention controlled drug delivery system |
| 09/06/2011 | CA2656181C Compressed preparation of compositions comprising olmesartan medoxomil |
| 09/06/2011 | CA2493785C Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 09/06/2011 | CA2488642C Aryl carbonyl derivatives as glucokinase activators |
| 09/06/2011 | CA2465746C Hydrazono-malonitriles |
| 09/06/2011 | CA2439410C Analogs of thalidomide as potential angiogenesis inhibitors |
| 09/06/2011 | CA2411882C Solid valsartan pharmaceutical compositions |
| 09/06/2011 | CA2373360C Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 09/01/2011 | WO2011106365A1 Modulation of angiogenesis |
| 09/01/2011 | WO2011106226A2 Prolylhydroxylase inhibitors and methods of use |
| 09/01/2011 | WO2011105643A1 Selenalzole derivative having ligand which activates peroxisome proliferator activated receptor (ppar), preparing method thereof and usage of the chemical compounds |
| 09/01/2011 | WO2011105458A1 Adhesive patch containing bisoprolol |
| 09/01/2011 | WO2011105099A1 Compound containing a novel 4-alkoxypyridine formation and medicine containing same |
| 09/01/2011 | WO2011104584A1 Pyrrolidine substituted flavones for the treatment of inflammatory disorders |
| 09/01/2011 | WO2011104340A1 Thienopyrimidines containing a substituted alkyl group for pharmaceutical compositions |
| 09/01/2011 | WO2011104322A1 Bisaryl-bonded aryltriazolones and use thereof |
| 09/01/2011 | WO2011104215A1 Biodegradable material containing silicon, for pro-angiogenetic therapy |
| 09/01/2011 | WO2011103789A1 Capsule of complex danshen drop pill |
| 09/01/2011 | WO2011041639A3 Heteroatom containing substituted fatty acids |
| 09/01/2011 | WO2011017554A4 Val (8) glp-1 composition and method for treating functional dyspepsia and/or irritable bowel syndrome |
| 09/01/2011 | WO2010050794A8 Cardioprotective effects of nutraceuticals isolated from nigella sativa seeds |
| 09/01/2011 | US20110213147 New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents |
| 09/01/2011 | US20110213029 3,4-Di-Substituted Cyclobutene-1,2-Diones as CXC-Chemokine Receptor Ligands |
| 09/01/2011 | US20110213027 Use of dronedarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or of mortality |
| 09/01/2011 | US20110213024 Two types of crystalline of pinocembrin, their preparation and their use for manufacture of pharmaceutical compositions |
| 09/01/2011 | US20110213018 Compositions and methods for regulation of smooth muscle cells and blood pressure |
| 09/01/2011 | US20110213004 Method of using combination preparation comprising angiotensin-ii-receptor blocker and hmg-coa reductase inhibitor |
| 09/01/2011 | US20110213002 Macrocyclic diterpenes for treating conditions associated with protein kinase c |
| 09/01/2011 | US20110213000 N-(2-thiazolyl)-amide derivatives for the treatment of obesity, diabetes and cardiovascular diseases |
| 09/01/2011 | US20110212999 Triazole derivatives and their use as nicotinic acetylcholine receptor modulators |
| 09/01/2011 | US20110212989 Therapeutic methods and compositions involving isoflavones |
| 09/01/2011 | US20110212983 Platelet adp receptor inhibitors |
| 09/01/2011 | US20110212963 Alkylthiazol carbamate derivatives, preparation thereof and therapeutic use thereof |
| 09/01/2011 | US20110212960 New compounds for the treatment of cns disorder |
| 09/01/2011 | US20110212959 Cyanoisoquinoline Compounds and Methods of Use Thereof |
| 09/01/2011 | US20110212958 Fatty acid raloxifene derivatives and their uses |
| 09/01/2011 | US20110212951 Human protein tyrosine phosphatase inhibitors and methods of use |
| 09/01/2011 | US20110212950 4,4-disubstituted piperidines |
| 09/01/2011 | US20110212947 Substituted indole compounds having nos inhibitory activity |
| 09/01/2011 | US20110212940 S1P Receptor Modulating Compounds and Use Thereof |
| 09/01/2011 | US20110212930 Lactam-containing compounds and derivatives thereof as factor xa inhibitors |
| 09/01/2011 | US20110212925 Novel compounds as receptor modulators with therapeutic utility |
| 09/01/2011 | US20110212924 Compositions and methods to treat cardiac diseases |
| 09/01/2011 | US20110212923 Phosphate Derivatives of Substituted Benzoxazoles |
| 09/01/2011 | US20110212915 Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them |
| 09/01/2011 | US20110212914 Stabilized pentosan polysulfate (pps) formulations and methods of analyzing them |
| 09/01/2011 | US20110212910 Antioxidant |
| 09/01/2011 | US20110212909 Use of Ginsenoside Compound K in the Preparation of a Medicament for the Prevention and Treatment of Atherosclerosis |
| 09/01/2011 | US20110212907 Hexadecasaccharides with antithrombotic activity, including a covalent bond and an amino chain |
| 09/01/2011 | US20110212905 Crystalline form of 1-(beta-d-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene hemihydrate |
| 09/01/2011 | US20110212896 Peptides for the treatment of oxidative stress related disorders |
| 09/01/2011 | US20110212887 Methods of treating obesity using enterostatin |
| 09/01/2011 | US20110212191 Composition for the maintenance of blood sugar levels comprising cinnamon and ginseng |
| 09/01/2011 | US20110212188 Preventing and/or treating cardiovascular disease and/or associated heart failure |
| 09/01/2011 | US20110212183 Antioxidant composition for marine oils comprising tocopherol, rosemary extract, ascorbic acid and green tea extract |
| 09/01/2011 | US20110212178 Injectable Hydrogel Filaments For Biomedical Uses |
| 09/01/2011 | US20110212175 Combination preparation comprising angiotensin-ii-receptor blocker and hmg-coa reductase inhibitor |
| 09/01/2011 | US20110212165 Pharmaceutical compositions of the isolated d-enantiomer of the quinazolinone derivative halofuginone |
| 09/01/2011 | US20110212139 High-density lipoprotein coated medical devices |
| 09/01/2011 | US20110212103 Thienopyrimidines containing a substituted alkyl group for pharmaceutical compositions |
| 09/01/2011 | US20110212097 Methods and Compositions to Treat and Detect Misfolded-SOD1 Mediated Diseases |
| 09/01/2011 | US20110212096 Anti-p-selectin antibodies and methods of their use and identification |
| 09/01/2011 | US20110212094 Dual variable domain immunoglobulins and uses thereof |
| 09/01/2011 | US20110212082 Method for producing tablet comprising natural allicin |
| 09/01/2011 | US20110212072 Inhibitors of Fatty Acid Oxidation for Prophylaxis and Treatment of Diseases Related to Mitochondrial Dysfunction |